Watson Pharmaceuticals, Inc. (NYSE-WPI) is a global specialty pharmaceutical company with approximately $3 billion in revenues, a broad product line and operations in well-established and emerging markets. We are focused on enhancing our commercial position in global generics and brands; improving our cost structure; targeting products in generics, brands and biopharmaceuticals that will deliver long-term growth; and recruiting and retaining the most talented and committed employees in our industry. We are Watson – a global company with a world of opportunity.